NCT03317171View on ClinicalTrials.gov

Safety and Efficacy of a Flavonoids- and omega3s-based Compound for the Treatment of Muscular Dystrophies

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 28, 2016

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions

Muscular DystrophiesMuscle Inflammation

Interventions

DIETARY_SUPPLEMENT

Flavonoids, DHA, EPA

oral administration

DIETARY_SUPPLEMENT

placebo compound

oral administration

Trial Locations (1)

20122

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan

All Listed Sponsors

lead

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

OTHER

NCT03317171 - Safety and Efficacy of a Flavonoids- and omega3s-based Compound for the Treatment of Muscular Dystrophies | Biotech Hunter | Biotech Hunter